Fatema S Abdulhussein1, Hannah Chesser1, W John Boscardin2, Stephen E Gitelman1, Jenise C Wong1. 1. Division of Endocrinology, Department of Pediatrics, Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA. 2. Department of Medicine, Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
Abstract
Background: The impact of the coronavirus disease-2019 (COVID-19) pandemic on glycemic metrics in children is uncertain. This study evaluates the effect of the shelter-in-place (SIP) mandate on glycemic metrics in youth with type 1 diabetes (T1D) using continuous glucose monitoring (CGM) in Northern California, United States. Methods: CGM and insulin pump metrics in youth 3-21 years old with T1D at an academic pediatric diabetes center were analyzed retrospectively. Data 2-4 months before (distant pre-SIP), 1 month before (immediate pre-SIP), 1 month after (immediate post-SIP), and 2-4 months after (distant post-SIP) the SIP mandate were compared using paired t-tests, linear regression, and longitudinal analysis using a mixed effects model. Results: Participants (n = 85) had reduced mean glucose (-10.3 ± 4.4 mg/dL, P = 0.009), standard deviation (SD) (-5.0 ± 1.3 mg/dL, P = 0.003), glucose management indicator (-0.2% ± 0.03%, P = 0.004), time above range (TAR) >250 mg/dL (-3.5% ± 1.7%, P = 0.01), and increased time in range (TIR) (+4.7% ± 1.7%, P = 0.0025) between the distant pre-SIP and distant post-SIP periods. Relationships were maintained using a mixed effects model, when controlling for other demographic variables. There was improvement in SD, TAR 180-250 mg/dL, and TIR for participants with private insurance, but changes in the opposite direction for participants with public insurance. Conclusions: Improvement in CGM metrics in youth with T1D during the COVID-19 pandemic suggests that diabetes management can be maintained in the face of sudden changes to daily living. Youth with public insurance deserve more attention in research and clinical practice.
Background: The impact of the coronavirus disease-2019 (COVID-19) pandemic on glycemic metrics in children is uncertain. This study evaluates the effect of the shelter-in-place (SIP) mandate on glycemic metrics in youth with type 1 diabetes (T1D) using continuous glucose monitoring (CGM) in Northern California, United States. Methods: CGM and insulin pump metrics in youth 3-21 years old with T1D at an academic pediatric diabetes center were analyzed retrospectively. Data 2-4 months before (distant pre-SIP), 1 month before (immediate pre-SIP), 1 month after (immediate post-SIP), and 2-4 months after (distant post-SIP) the SIP mandate were compared using paired t-tests, linear regression, and longitudinal analysis using a mixed effects model. Results: Participants (n = 85) had reduced mean glucose (-10.3 ± 4.4 mg/dL, P = 0.009), standard deviation (SD) (-5.0 ± 1.3 mg/dL, P = 0.003), glucose management indicator (-0.2% ± 0.03%, P = 0.004), time above range (TAR) >250 mg/dL (-3.5% ± 1.7%, P = 0.01), and increased time in range (TIR) (+4.7% ± 1.7%, P = 0.0025) between the distant pre-SIP and distant post-SIP periods. Relationships were maintained using a mixed effects model, when controlling for other demographic variables. There was improvement in SD, TAR 180-250 mg/dL, and TIR for participants with private insurance, but changes in the opposite direction for participants with public insurance. Conclusions: Improvement in CGM metrics in youth with T1D during the COVID-19 pandemic suggests that diabetes management can be maintained in the face of sudden changes to daily living. Youth with public insurance deserve more attention in research and clinical practice.
Entities:
Keywords:
COVID-19; Continuous glucose monitoring; Pediatrics; Time in range; Type 1 diabetes
Authors: Sahar K Alharthi; Ebtihal Y Alyusuf; Abdullah M Alguwaihes; Assim Alfadda; Mohammed E Al-Sofiani Journal: Diabetes Res Clin Pract Date: 2021-02-02 Impact factor: 5.602
Authors: Monika K Goyal; Joelle N Simpson; Meleah D Boyle; Gia M Badolato; Meghan Delaney; Robert McCarter; Denice Cora-Bramble Journal: Pediatrics Date: 2020-08-05 Impact factor: 7.124
Authors: Tadej Battelino; Thomas Danne; Richard M Bergenstal; Stephanie A Amiel; Roy Beck; Torben Biester; Emanuele Bosi; Bruce A Buckingham; William T Cefalu; Kelly L Close; Claudio Cobelli; Eyal Dassau; J Hans DeVries; Kim C Donaghue; Klemen Dovc; Francis J Doyle; Satish Garg; George Grunberger; Simon Heller; Lutz Heinemann; Irl B Hirsch; Roman Hovorka; Weiping Jia; Olga Kordonouri; Boris Kovatchev; Aaron Kowalski; Lori Laffel; Brian Levine; Alexander Mayorov; Chantal Mathieu; Helen R Murphy; Revital Nimri; Kirsten Nørgaard; Christopher G Parkin; Eric Renard; David Rodbard; Banshi Saboo; Desmond Schatz; Keaton Stoner; Tatsuiko Urakami; Stuart A Weinzimer; Moshe Phillip Journal: Diabetes Care Date: 2019-06-08 Impact factor: 19.112
Authors: Jedrek Wosik; Marat Fudim; Blake Cameron; Ziad F Gellad; Alex Cho; Donna Phinney; Simon Curtis; Matthew Roman; Eric G Poon; Jeffrey Ferranti; Jason N Katz; James Tcheng Journal: J Am Med Inform Assoc Date: 2020-06-01 Impact factor: 4.497
Authors: Barbara Predieri; Francesco Leo; Francesco Candia; Laura Lucaccioni; Simona F Madeo; Marisa Pugliese; Valentina Vivaccia; Patrizia Bruzzi; Lorenzo Iughetti Journal: Front Endocrinol (Lausanne) Date: 2020-12-07 Impact factor: 5.555
Authors: Osagie Ebekozien; Shivani Agarwal; Nudrat Noor; Anastasia Albanese-O'Neill; Jenise C Wong; Tossaporn Seeherunvong; Janine Sanchez; Daniel DeSalvo; Sarah K Lyons; Shideh Majidi; Jamie R Wood; Runa Acharya; Grazia Aleppo; Kathryn M Sumpter; Anna Cymbaluk; Nirali A Shah; Michelle Van Name; Lisa Cruz-Aviles; Guy Todd Alonso; Mary Pat Gallagher; Srinath Sanda; Alexis Jamie Feuer; Kristina Cossen; Nicole Rioles; Nana-Hawa Yayah Jones; Manmohan K Kamboj; Irl B Hirsch Journal: J Clin Endocrinol Metab Date: 2021-03-25 Impact factor: 5.958
Authors: Richard M Bergenstal; Roy W Beck; Kelly L Close; George Grunberger; David B Sacks; Aaron Kowalski; Adam S Brown; Lutz Heinemann; Grazia Aleppo; Donna B Ryan; Tonya D Riddlesworth; William T Cefalu Journal: Diabetes Care Date: 2018-09-17 Impact factor: 19.112